| |
| | |
Expressed Recombinant Protein | | |  |
Darryl L. Goss joins Bioreliance
Darryl L. Goss has been appointed Vice
President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly
formed Business Unit.
Click here to read the
press release.
|
|
|
|
|
BioReliance has significant experience in producing and testing gene therapy viral vectors.
|
The expression of the specific recombinant protein in serum samples is detected by using immunoassays such as ELISA. BioReliance works with the sponsor to develop a specific assay or to transfer an assay from the sponsor. BioReliance qualifies the assay for use on a variety of patient sample materials.
|  |
|
|
